 Ottawa doctors' high-risk MS treatment yields 'impressive' results, Lancet finds  New Canadian research led by two Ottawa doctors and published in The Lancet medical journal on Thursday suggests a high-risk therapy may stop multiple sclerosis from progressing, and even reverse the disease.CommentsYou need to be a member of CKA and be logged into the site, to comment on news. |
Share
|
Mobile
All logos and trademarks in this site are property of their respective owner.
The comments are property of their posters, all the rest © 2025 by Canadaka.net
The comments are property of their posters, all the rest © 2025 by Canadaka.net